Human Recombinant FAM19A4 protein, hFc Tag (V2LY-0526-LY4002)

Go to compare Compare Online Inquiry
Request for COA
Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Expressed Host
HEK293 Cells
Protein Species
Human
Tag
hFc Tag
Protein Construction
This product is Human Recombinant FAM19A4 protein, hFc Tag consist of Amino Acid: 36-140 and predicts a molecular mass of 40.1 kDa.
Molecule Mass
40.1 kDa
Sequence
Amino Acid: 36-140
Species
Human

Formulations & Storage [For reference only, actual COA shall prevail!]

Purity
>80% as determined by SDS-PAGE
Endotoxin
Please contact us for more information.
Format
Lyophilized
Reconstitution
Allow the vial and reconstitution buffer to equilibrate to room temperature. Briefly centrifuge or tap down the vial to ensure that all lyophilized powder is collected at the bottom of the vial. For the reconstitution of this product, we recommend adding PBS or sterile water to achieve a final antibody concentration of 1 mg/mL. Allow the vial to reconstitute for 10-15 minutes at room temperature with gentle agitation. Avoid vigorous shaking that can cause foaming and antibody denaturation. Aliquot into volumes based on your experiment and store liquid protein at -20°C or -80°C for long time.
Buffer
Lyophilized from sterile Tirs, NaCl, Glycerol
Preservative
None
Storage
Samples are stable for up to twelve months from date of receipt at -20°C to -80°C. Store it under sterile conditions at -20°C to -80°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
More Infomation

Target

Full Name
Family With Sequence Similarity 19 Member A4, C-C Motif Chemokine Like
Research Area
Modulates injury-induced and chemical pain hypersensitivity (By similarity).

Ligand of FPR1, can chemoattract macrophages, promote phagocytosis and increase ROS release (PubMed:25109685).
Biological Process
Macrophage chemotaxis Source: UniProtKB
Phagocytosis Source: UniProtKB
Regulation of membrane potential Source: Ensembl
Regulation of sensory perception of pain Source: Ensembl
Regulation of signaling receptor activity Source: UniProtKB
Superoxide anion generation Source: UniProtKB
Cellular Location
Secreted

van Trommel, N., Kremer, W., Dick, S., Heideman, D., Steenbergen, R., Bleeker, M., ... & Berkhof, J. (2022). 2022-RA-1253-ESGO CONCERVE study demonstrates that clinical regression of high-grade cervical intraepithelial neoplasia is associated with absence of FAM19A4/miR124–2 DNA methylation.

Kremer, W. W., Dick, S., Heideman, D. A., Steenbergen, R. D., Bleeker, M. C., Verhoeve, H. R., ... & Berkhof, J. (2022). Clinical regression of high-grade cervical intraepithelial neoplasia is associated with absence of FAM19A4/miR124-2 DNA methylation (CONCERVE study). Journal of Clinical Oncology, 40(26), 3037-3046.

Hampl, M., Hesselink, B., Meijer, C., Denecke, A., Einhorn, I., Jentschke, M., ... & Hillemanns, P. (2022). 2022-RA-1264-ESGO Evaluation of managing CIN 3 plus diagnosed pregnant women by methylation assessment using FAM19A4/miR124 methylation test.

Dick, S., Vink, F. J., Heideman, D. A., Lissenberg-Witte, B. I., Meijer, C. J., & Berkhof, J. (2022). Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping. British journal of cancer, 126(2), 259-264.

Bonde, J., Floore, A., Ejegod, D., Vink, F. J., Hesselink, A., van de Ven, P. M., ... & Heideman, D. A. (2021). Methylation markers FAM19A4 and miR124‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study. International journal of cancer, 148(2), 396-405.

Vink, F. J., Dick, S., Heideman, D. A., De Strooper, L. M., Steenbergen, R. D., Lissenberg‐Witte, B. I., ... & Meijer, C. J. (2021). Classification of high‐grade cervical intraepithelial neoplasia by p16ink4a, Ki‐67, HPV E4 and FAM19A4/miR124‐2 methylation status demonstrates considerable heterogeneity with potential consequences for management. International Journal of Cancer, 149(3), 707-716.

Vink, F. J., Meijer, C. J., Clifford, G. M., Poljak, M., Oštrbenk, A., Petry, K. U., ... & Heideman, D. A. (2020). FAM19A4/miR124‐2 methylation in invasive cervical cancer: a retrospective cross‐sectional worldwide study. International Journal of Cancer, 147(4), 1215-1221.

Dick, S., Kremer, W. W., De Strooper, L. M., Lissenberg-Witte, B. I., Steenbergen, R. D., Meijer, C. J., ... & Heideman, D. A. (2019). Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis. Gynecologic Oncology, 154(2), 368-373.

De Strooper, L. M., Berkhof, J., Steenbergen, R. D., Lissenberg‐Witte, B. I., Snijders, P. J., Meijer, C. J., & Heideman, D. A. (2018). Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: a post hoc analysis in the POBASCAM trial with 14 year follow‐up. International Journal of Cancer, 143(6), 1541-1548.

Bu, Q., Wang, S., Ma, J., Zhou, X., Hu, G., Deng, H., ... & Luo, X. (2018). The clinical significance of FAM19A4 methylation in high-risk HPV-positive cervical samples for the detection of cervical (pre) cancer in Chinese women. BMC cancer, 18(1), 1-10.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Human Recombinant FAM19A4 protein, hFc Tag?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

online inquiry
Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.